SlideShare a Scribd company logo
1 of 2
Download to read offline
TIME IS OF THE ESSENCE IN DRUG DEVELOPMENT.
CONTACT THE QPS BUSINESS DEVELOPMENT TEAM TODAY!
CALL +1 512 350 2827 EMAIL infobd@qps.com
DMPK
A flexible approach to
QPS DMPK PROVIDES A DEDICATED
TEAM OF SENIOR SCIENTISTS TO HELP SELECT,
design and conduct the appropriate ADME studies
for your specific compounds and therapeutic targets.
Working with QPS DMPK is a collaborative and consultative
endeavor that also incorporates our operational effectiveness
and dedication to customer service.
Fargo, ND, USA
Dermal and Transdermal
Research Laboratory (DTRL)
Groningen and Leeuwarden,
The Netherlands
Bioanalysis (BA)
Clinical Research Services (CRS)
Translational Medicine (TLM)
Suzhou and Shanghai,
China
Bioanalysis (BA)
Clinical Research Services (CRS)
Miami, FL, USA
Clinical Research
Services (CRS)
Hyderabad, India
Bioanalysis (BA)
Clinical Research
Services (CRS)
Taipei, Taiwan
Bioanalysis (BA)
Clinical Research Services (CRS)
Toxicology (TOX)
Newark, DE, USA
Bioanalysis (BA)
Clinical Research Services (CRS)
DMPK
Translational Medicine (TLM)
Global Headquarters for
QPS Holdings LLC
Graz, Austria
Clinical Research Services (CRS)
DMPK
Histology Services
Neuropharmacology
Rare Disease
Rodent Biobank
Springfield, MO, USA
Clinical Research
Services (CRS)
Macro & Micro Autoradiography
One of QPS’ main services in DMPK is the combined mass
balance, biliary excretion, PK, and QWBA studies.
	
f Increased efficiency by using a single study protocol
	
f Better study oversight with an integrated study report
	
f Elimination of the possibility of radiolabel degrading over
an extended period of time between the two studies
	
f Metabolite profiling and identification can be done using
the samples from the same study
	
f Micro-autoradiography provides insight into sub-cellular
tissue distribution
Biotransformation
QPS biotransformation studies determine how a molecule
may be altered by the action of enzymes. These study
types include:
	
f In vitro metabolic stability in hepatic subcellular fractions
to determine intrinsic clearance
	
f In vitro comparison of metabolite formation in animal
and human hepatic preparations, using non-labeled and
radio-labeled test articles
	
f In vivo metabolite profiling, identification and
quantification using samples collected from animal PK,
mass balance excretion studies, and human AME studies
to satisfy Metabolites in Safety Testing (MIST)
Protein Binding
QPS protein binding studies determine the extent of
protein binding in various plasma species and tissues.
	
f Methods: equilibrium dialysis (RED, Harvard device, 96-
well HTD), ultrafiltration, and ultracentrifugation
	
f Discovery screening, in vitro protein binding for IND, and
ex vivo studies in clinical phases
	
f Experience in compounds with very high binding, stability
issues, or non-specific issues
Drug-Drug Interaction
QPS drug interaction studies determine the potential of
a substance to alter cytochrome P450 activity. Studies
conducted to assess inhibition and induction potential
to support discovery and development of new drug
candidates are:
	
f In vitro inhibition characterization in human liver
microsomes or hepatocytes to determine reversible or
time dependent IC50
	
f In vitro mechanistic characterization of reversible
inhibitory rate constants Ki
	
f Identification of the reversible mechanism of inhibition as
competitive, non-competitive or uncompetitive
	
f In vitro mechanistic characterization of time dependent
inhibition Kinact
and KI
	
f Identification of the mechanism of time dependent
inhibition as metabolite mediated via covalent
modification or due to tight binding effect of substrate
	
f In vitro characterization of CYP1A2, CYP2B6, and CYP3A4
induction potential in human hepatocytes based on
mRNA and/or CYP activity using isoform selective probe
substrates
QPS is a Global CRO with locations around the world
WWW.QPS.COM

More Related Content

What's hot

DerekLadBuhrCoverLetter2015
DerekLadBuhrCoverLetter2015DerekLadBuhrCoverLetter2015
DerekLadBuhrCoverLetter2015Derek Lad Buhr
 
Tsrl modified dosage forms august_non-confidential
Tsrl modified dosage forms august_non-confidentialTsrl modified dosage forms august_non-confidential
Tsrl modified dosage forms august_non-confidentialDrew Hertig, MBA, CLP
 
Tsrl fact sheet potent dna therapeutics may 2016
Tsrl fact sheet potent dna therapeutics may 2016Tsrl fact sheet potent dna therapeutics may 2016
Tsrl fact sheet potent dna therapeutics may 2016Drew Hertig, MBA, CLP
 
Introduction to the TSRL, Inc. Accelerator Model
Introduction to the TSRL, Inc. Accelerator ModelIntroduction to the TSRL, Inc. Accelerator Model
Introduction to the TSRL, Inc. Accelerator ModelDrew Hertig, MBA, CLP
 
TSRL Fact Sheet_Preclinical Accelerator_June 2016
TSRL Fact Sheet_Preclinical Accelerator_June 2016TSRL Fact Sheet_Preclinical Accelerator_June 2016
TSRL Fact Sheet_Preclinical Accelerator_June 2016Drew Hertig, MBA, CLP
 
The Integrated Early Drug Development Platform White Paper
The Integrated Early Drug Development Platform White PaperThe Integrated Early Drug Development Platform White Paper
The Integrated Early Drug Development Platform White PaperCovance
 
QPS IND Proof-of-Concept Flyer
QPS IND Proof-of-Concept FlyerQPS IND Proof-of-Concept Flyer
QPS IND Proof-of-Concept FlyerQPS Holdings, LLC
 
ExL Pharma Clinical Trials Phase I and Phase IIa Conference Brochure: Phase 1...
ExL Pharma Clinical Trials Phase I and Phase IIa Conference Brochure: Phase 1...ExL Pharma Clinical Trials Phase I and Phase IIa Conference Brochure: Phase 1...
ExL Pharma Clinical Trials Phase I and Phase IIa Conference Brochure: Phase 1...bryonmain
 
Effective Late Stage Pathways for Biosimilar Products
Effective Late Stage Pathways for Biosimilar ProductsEffective Late Stage Pathways for Biosimilar Products
Effective Late Stage Pathways for Biosimilar ProductsPAREXEL International
 
ctt-mediaKit_010411v1_spreads
ctt-mediaKit_010411v1_spreadsctt-mediaKit_010411v1_spreads
ctt-mediaKit_010411v1_spreadsTracy Critchfield
 
Attention to Detail Drives APH Assay Quality
Attention to Detail Drives APH Assay QualityAttention to Detail Drives APH Assay Quality
Attention to Detail Drives APH Assay QualityCovance
 
Chemometrics, Pharmacometrics and Econometrics Dimensions_of_Quality
Chemometrics, Pharmacometrics and Econometrics Dimensions_of_QualityChemometrics, Pharmacometrics and Econometrics Dimensions_of_Quality
Chemometrics, Pharmacometrics and Econometrics Dimensions_of_QualityAjaz Hussain
 
Professional Services Snapshot Overview
Professional Services Snapshot OverviewProfessional Services Snapshot Overview
Professional Services Snapshot Overviewpaulinekearse
 
Todd Lewis Resume
Todd Lewis ResumeTodd Lewis Resume
Todd Lewis ResumeTodd Lewis
 
Visioning the Next Decade: NIPTE-FDA Collaboration
Visioning the Next Decade: NIPTE-FDA CollaborationVisioning the Next Decade: NIPTE-FDA Collaboration
Visioning the Next Decade: NIPTE-FDA CollaborationAjaz Hussain
 

What's hot (20)

How new drugs_are_developed_1_ (1)
How new drugs_are_developed_1_ (1)How new drugs_are_developed_1_ (1)
How new drugs_are_developed_1_ (1)
 
DerekLadBuhrCoverLetter2015
DerekLadBuhrCoverLetter2015DerekLadBuhrCoverLetter2015
DerekLadBuhrCoverLetter2015
 
Tsrl modified dosage forms august_non-confidential
Tsrl modified dosage forms august_non-confidentialTsrl modified dosage forms august_non-confidential
Tsrl modified dosage forms august_non-confidential
 
Tsrl fact sheet potent dna therapeutics may 2016
Tsrl fact sheet potent dna therapeutics may 2016Tsrl fact sheet potent dna therapeutics may 2016
Tsrl fact sheet potent dna therapeutics may 2016
 
Pharmaceuticals Dashboard 2021
Pharmaceuticals Dashboard 2021Pharmaceuticals Dashboard 2021
Pharmaceuticals Dashboard 2021
 
Introduction to the TSRL, Inc. Accelerator Model
Introduction to the TSRL, Inc. Accelerator ModelIntroduction to the TSRL, Inc. Accelerator Model
Introduction to the TSRL, Inc. Accelerator Model
 
TSRL Fact Sheet_Preclinical Accelerator_June 2016
TSRL Fact Sheet_Preclinical Accelerator_June 2016TSRL Fact Sheet_Preclinical Accelerator_June 2016
TSRL Fact Sheet_Preclinical Accelerator_June 2016
 
CV_AN
CV_ANCV_AN
CV_AN
 
The Integrated Early Drug Development Platform White Paper
The Integrated Early Drug Development Platform White PaperThe Integrated Early Drug Development Platform White Paper
The Integrated Early Drug Development Platform White Paper
 
QPS IND Proof-of-Concept Flyer
QPS IND Proof-of-Concept FlyerQPS IND Proof-of-Concept Flyer
QPS IND Proof-of-Concept Flyer
 
ExL Pharma Clinical Trials Phase I and Phase IIa Conference Brochure: Phase 1...
ExL Pharma Clinical Trials Phase I and Phase IIa Conference Brochure: Phase 1...ExL Pharma Clinical Trials Phase I and Phase IIa Conference Brochure: Phase 1...
ExL Pharma Clinical Trials Phase I and Phase IIa Conference Brochure: Phase 1...
 
Effective Late Stage Pathways for Biosimilar Products
Effective Late Stage Pathways for Biosimilar ProductsEffective Late Stage Pathways for Biosimilar Products
Effective Late Stage Pathways for Biosimilar Products
 
ctt-mediaKit_010411v1_spreads
ctt-mediaKit_010411v1_spreadsctt-mediaKit_010411v1_spreads
ctt-mediaKit_010411v1_spreads
 
Working for Dedevan
Working for DedevanWorking for Dedevan
Working for Dedevan
 
Attention to Detail Drives APH Assay Quality
Attention to Detail Drives APH Assay QualityAttention to Detail Drives APH Assay Quality
Attention to Detail Drives APH Assay Quality
 
Chemometrics, Pharmacometrics and Econometrics Dimensions_of_Quality
Chemometrics, Pharmacometrics and Econometrics Dimensions_of_QualityChemometrics, Pharmacometrics and Econometrics Dimensions_of_Quality
Chemometrics, Pharmacometrics and Econometrics Dimensions_of_Quality
 
Professional Services Snapshot Overview
Professional Services Snapshot OverviewProfessional Services Snapshot Overview
Professional Services Snapshot Overview
 
Todd Lewis Resume
Todd Lewis ResumeTodd Lewis Resume
Todd Lewis Resume
 
Visioning the Next Decade: NIPTE-FDA Collaboration
Visioning the Next Decade: NIPTE-FDA CollaborationVisioning the Next Decade: NIPTE-FDA Collaboration
Visioning the Next Decade: NIPTE-FDA Collaboration
 
UC BRAID D4
UC BRAID D4UC BRAID D4
UC BRAID D4
 

Similar to QPS DMPK

QPS Radiolabeled ADME Studies
QPS Radiolabeled ADME StudiesQPS Radiolabeled ADME Studies
QPS Radiolabeled ADME StudiesQPS Holdings, LLC
 
QPS Global Capabilities Presentation
QPS Global Capabilities PresentationQPS Global Capabilities Presentation
QPS Global Capabilities PresentationEdwin van Vulpen
 
QPS LC-MS MS of Small & Large Molecules
QPS LC-MS MS of Small & Large MoleculesQPS LC-MS MS of Small & Large Molecules
QPS LC-MS MS of Small & Large MoleculesQPS Holdings, LLC
 
PRINCIPLES OF DRUG DISCOVERY & DEVELOPMENT.pptx
PRINCIPLES OF DRUG DISCOVERY & DEVELOPMENT.pptxPRINCIPLES OF DRUG DISCOVERY & DEVELOPMENT.pptx
PRINCIPLES OF DRUG DISCOVERY & DEVELOPMENT.pptxDharaMehta45
 
PRINCIPLES OF DRUG DISCOVERY & DEVELOPMENT.pptx
PRINCIPLES OF DRUG DISCOVERY & DEVELOPMENT.pptxPRINCIPLES OF DRUG DISCOVERY & DEVELOPMENT.pptx
PRINCIPLES OF DRUG DISCOVERY & DEVELOPMENT.pptxDharaMehta45
 
Hao Liu Resume 2017-02
Hao Liu Resume 2017-02Hao Liu Resume 2017-02
Hao Liu Resume 2017-02Hao Liu
 
BioExpo 2023 Presentation - Computational Chemistry in Drug Discovery: Bridgi...
BioExpo 2023 Presentation - Computational Chemistry in Drug Discovery: Bridgi...BioExpo 2023 Presentation - Computational Chemistry in Drug Discovery: Bridgi...
BioExpo 2023 Presentation - Computational Chemistry in Drug Discovery: Bridgi...Trustlife
 
DerekPoore 2015 CV
DerekPoore 2015 CVDerekPoore 2015 CV
DerekPoore 2015 CVDerek Poore
 
Deecher D Cv 3.5.09
Deecher D Cv 3.5.09Deecher D Cv 3.5.09
Deecher D Cv 3.5.09guest20d1ac
 
Ouellette, Michael_Resume 2016
Ouellette, Michael_Resume 2016Ouellette, Michael_Resume 2016
Ouellette, Michael_Resume 2016Mike Ouellette
 
biomarcare_journal.pone.0159522.PDF
biomarcare_journal.pone.0159522.PDFbiomarcare_journal.pone.0159522.PDF
biomarcare_journal.pone.0159522.PDFOuriel Faktor
 

Similar to QPS DMPK (20)

QPS Neuropharmacology
QPS NeuropharmacologyQPS Neuropharmacology
QPS Neuropharmacology
 
QPS Radiolabeled ADME Studies
QPS Radiolabeled ADME StudiesQPS Radiolabeled ADME Studies
QPS Radiolabeled ADME Studies
 
Targos_Company_Brochure_lowres
Targos_Company_Brochure_lowresTargos_Company_Brochure_lowres
Targos_Company_Brochure_lowres
 
Targos_Company_Brochure_lowres
Targos_Company_Brochure_lowresTargos_Company_Brochure_lowres
Targos_Company_Brochure_lowres
 
Drug Design:Discovery, Development and Delivery
Drug Design:Discovery, Development and DeliveryDrug Design:Discovery, Development and Delivery
Drug Design:Discovery, Development and Delivery
 
QPS Global Capabilities Presentation
QPS Global Capabilities PresentationQPS Global Capabilities Presentation
QPS Global Capabilities Presentation
 
QPS LC-MS MS of Small & Large Molecules
QPS LC-MS MS of Small & Large MoleculesQPS LC-MS MS of Small & Large Molecules
QPS LC-MS MS of Small & Large Molecules
 
PRINCIPLES OF DRUG DISCOVERY & DEVELOPMENT.pptx
PRINCIPLES OF DRUG DISCOVERY & DEVELOPMENT.pptxPRINCIPLES OF DRUG DISCOVERY & DEVELOPMENT.pptx
PRINCIPLES OF DRUG DISCOVERY & DEVELOPMENT.pptx
 
PRINCIPLES OF DRUG DISCOVERY & DEVELOPMENT.pptx
PRINCIPLES OF DRUG DISCOVERY & DEVELOPMENT.pptxPRINCIPLES OF DRUG DISCOVERY & DEVELOPMENT.pptx
PRINCIPLES OF DRUG DISCOVERY & DEVELOPMENT.pptx
 
Lisa_Grimm
Lisa_GrimmLisa_Grimm
Lisa_Grimm
 
Hao Liu Resume 2017-02
Hao Liu Resume 2017-02Hao Liu Resume 2017-02
Hao Liu Resume 2017-02
 
BioExpo 2023 Presentation - Computational Chemistry in Drug Discovery: Bridgi...
BioExpo 2023 Presentation - Computational Chemistry in Drug Discovery: Bridgi...BioExpo 2023 Presentation - Computational Chemistry in Drug Discovery: Bridgi...
BioExpo 2023 Presentation - Computational Chemistry in Drug Discovery: Bridgi...
 
DerekPoore 2015 CV
DerekPoore 2015 CVDerekPoore 2015 CV
DerekPoore 2015 CV
 
Deecher D Cv 3.5.09
Deecher D Cv 3.5.09Deecher D Cv 3.5.09
Deecher D Cv 3.5.09
 
Lisa_Grimm
Lisa_GrimmLisa_Grimm
Lisa_Grimm
 
QPS CSF Sampling
QPS CSF SamplingQPS CSF Sampling
QPS CSF Sampling
 
MDC Connects: Target discovery at AstraZeneca
MDC Connects: Target discovery at AstraZenecaMDC Connects: Target discovery at AstraZeneca
MDC Connects: Target discovery at AstraZeneca
 
Ouellette, Michael_Resume 2016
Ouellette, Michael_Resume 2016Ouellette, Michael_Resume 2016
Ouellette, Michael_Resume 2016
 
biomarcare_journal.pone.0159522.PDF
biomarcare_journal.pone.0159522.PDFbiomarcare_journal.pone.0159522.PDF
biomarcare_journal.pone.0159522.PDF
 
TFadra-Khan Resume
TFadra-Khan ResumeTFadra-Khan Resume
TFadra-Khan Resume
 

More from QPS Holdings, LLC

Defining a Full Service ADME Data Package
Defining a Full Service ADME Data Package Defining a Full Service ADME Data Package
Defining a Full Service ADME Data Package QPS Holdings, LLC
 
QPS Regulated Bioanalysis of Antibody Drug Conjugates
QPS Regulated Bioanalysis of Antibody Drug ConjugatesQPS Regulated Bioanalysis of Antibody Drug Conjugates
QPS Regulated Bioanalysis of Antibody Drug ConjugatesQPS Holdings, LLC
 
Overcoming Pediatric Trial Challenges
Overcoming Pediatric Trial ChallengesOvercoming Pediatric Trial Challenges
Overcoming Pediatric Trial ChallengesQPS Holdings, LLC
 
Three Lessons to Help Accelerate Pharmaceutical Breakthroughs for CNS Disorders
Three Lessons to Help Accelerate Pharmaceutical Breakthroughs for CNS DisordersThree Lessons to Help Accelerate Pharmaceutical Breakthroughs for CNS Disorders
Three Lessons to Help Accelerate Pharmaceutical Breakthroughs for CNS DisordersQPS Holdings, LLC
 
Pharmacokinetic Studies in Patients
Pharmacokinetic Studies in PatientsPharmacokinetic Studies in Patients
Pharmacokinetic Studies in PatientsQPS Holdings, LLC
 
Seeking Drug Approval via the 505(b)(2) NDA Option
Seeking Drug Approval via the 505(b)(2) NDA OptionSeeking Drug Approval via the 505(b)(2) NDA Option
Seeking Drug Approval via the 505(b)(2) NDA OptionQPS Holdings, LLC
 
Transdermal Delivery Systems
Transdermal Delivery SystemsTransdermal Delivery Systems
Transdermal Delivery SystemsQPS Holdings, LLC
 
Selecting the Location of a Phase I Clinical Trial Site for EU Registration
Selecting the Location of a Phase I Clinical Trial Site for EU RegistrationSelecting the Location of a Phase I Clinical Trial Site for EU Registration
Selecting the Location of a Phase I Clinical Trial Site for EU RegistrationQPS Holdings, LLC
 
ICP-MS for Elemental Analysis in Drug Development
ICP-MS for Elemental Analysis in Drug DevelopmentICP-MS for Elemental Analysis in Drug Development
ICP-MS for Elemental Analysis in Drug DevelopmentQPS Holdings, LLC
 
Large Molecule Bioanalysis: LC-MS or ELISA? A Case Study
Large Molecule Bioanalysis: LC-MS or ELISA? A Case StudyLarge Molecule Bioanalysis: LC-MS or ELISA? A Case Study
Large Molecule Bioanalysis: LC-MS or ELISA? A Case StudyQPS Holdings, LLC
 
QPS Human Mass Balance Presentation
QPS Human Mass Balance PresentationQPS Human Mass Balance Presentation
QPS Human Mass Balance PresentationQPS Holdings, LLC
 
QPS-NL Respiratory Capabilities Presentation
QPS-NL Respiratory Capabilities PresentationQPS-NL Respiratory Capabilities Presentation
QPS-NL Respiratory Capabilities PresentationQPS Holdings, LLC
 
Regulatory and Timeline Advantages for Early Clinical Research in The Netherl...
Regulatory and Timeline Advantages for Early Clinical Research in The Netherl...Regulatory and Timeline Advantages for Early Clinical Research in The Netherl...
Regulatory and Timeline Advantages for Early Clinical Research in The Netherl...QPS Holdings, LLC
 

More from QPS Holdings, LLC (20)

Defining a Full Service ADME Data Package
Defining a Full Service ADME Data Package Defining a Full Service ADME Data Package
Defining a Full Service ADME Data Package
 
QPS Bioanalysis General
QPS Bioanalysis General QPS Bioanalysis General
QPS Bioanalysis General
 
QPS Immunogenicity
QPS ImmunogenicityQPS Immunogenicity
QPS Immunogenicity
 
QPS Negative Pressure Room
QPS Negative Pressure RoomQPS Negative Pressure Room
QPS Negative Pressure Room
 
QPS Regulated Bioanalysis of Antibody Drug Conjugates
QPS Regulated Bioanalysis of Antibody Drug ConjugatesQPS Regulated Bioanalysis of Antibody Drug Conjugates
QPS Regulated Bioanalysis of Antibody Drug Conjugates
 
QPS Gene Therapy Milestones
QPS Gene Therapy MilestonesQPS Gene Therapy Milestones
QPS Gene Therapy Milestones
 
QPS Bioanalysis Milestones
QPS Bioanalysis MilestonesQPS Bioanalysis Milestones
QPS Bioanalysis Milestones
 
Overcoming Pediatric Trial Challenges
Overcoming Pediatric Trial ChallengesOvercoming Pediatric Trial Challenges
Overcoming Pediatric Trial Challenges
 
Biosimilar Dug Development
Biosimilar Dug DevelopmentBiosimilar Dug Development
Biosimilar Dug Development
 
Three Lessons to Help Accelerate Pharmaceutical Breakthroughs for CNS Disorders
Three Lessons to Help Accelerate Pharmaceutical Breakthroughs for CNS DisordersThree Lessons to Help Accelerate Pharmaceutical Breakthroughs for CNS Disorders
Three Lessons to Help Accelerate Pharmaceutical Breakthroughs for CNS Disorders
 
RNAi Therapeutics
RNAi TherapeuticsRNAi Therapeutics
RNAi Therapeutics
 
Pharmacokinetic Studies in Patients
Pharmacokinetic Studies in PatientsPharmacokinetic Studies in Patients
Pharmacokinetic Studies in Patients
 
Seeking Drug Approval via the 505(b)(2) NDA Option
Seeking Drug Approval via the 505(b)(2) NDA OptionSeeking Drug Approval via the 505(b)(2) NDA Option
Seeking Drug Approval via the 505(b)(2) NDA Option
 
Transdermal Delivery Systems
Transdermal Delivery SystemsTransdermal Delivery Systems
Transdermal Delivery Systems
 
Selecting the Location of a Phase I Clinical Trial Site for EU Registration
Selecting the Location of a Phase I Clinical Trial Site for EU RegistrationSelecting the Location of a Phase I Clinical Trial Site for EU Registration
Selecting the Location of a Phase I Clinical Trial Site for EU Registration
 
ICP-MS for Elemental Analysis in Drug Development
ICP-MS for Elemental Analysis in Drug DevelopmentICP-MS for Elemental Analysis in Drug Development
ICP-MS for Elemental Analysis in Drug Development
 
Large Molecule Bioanalysis: LC-MS or ELISA? A Case Study
Large Molecule Bioanalysis: LC-MS or ELISA? A Case StudyLarge Molecule Bioanalysis: LC-MS or ELISA? A Case Study
Large Molecule Bioanalysis: LC-MS or ELISA? A Case Study
 
QPS Human Mass Balance Presentation
QPS Human Mass Balance PresentationQPS Human Mass Balance Presentation
QPS Human Mass Balance Presentation
 
QPS-NL Respiratory Capabilities Presentation
QPS-NL Respiratory Capabilities PresentationQPS-NL Respiratory Capabilities Presentation
QPS-NL Respiratory Capabilities Presentation
 
Regulatory and Timeline Advantages for Early Clinical Research in The Netherl...
Regulatory and Timeline Advantages for Early Clinical Research in The Netherl...Regulatory and Timeline Advantages for Early Clinical Research in The Netherl...
Regulatory and Timeline Advantages for Early Clinical Research in The Netherl...
 

Recently uploaded

VIP ℂall Girls Arekere Bangalore 6378878445 WhatsApp: Me All Time Serviℂe Ava...
VIP ℂall Girls Arekere Bangalore 6378878445 WhatsApp: Me All Time Serviℂe Ava...VIP ℂall Girls Arekere Bangalore 6378878445 WhatsApp: Me All Time Serviℂe Ava...
VIP ℂall Girls Arekere Bangalore 6378878445 WhatsApp: Me All Time Serviℂe Ava...deepakkumar115120
 
Cara Menggugurkan Kandungan Dengan Cepat Selesai Dalam 24 Jam Secara Alami Bu...
Cara Menggugurkan Kandungan Dengan Cepat Selesai Dalam 24 Jam Secara Alami Bu...Cara Menggugurkan Kandungan Dengan Cepat Selesai Dalam 24 Jam Secara Alami Bu...
Cara Menggugurkan Kandungan Dengan Cepat Selesai Dalam 24 Jam Secara Alami Bu...Cara Menggugurkan Kandungan 087776558899
 
Cardiac Output, Venous Return, and Their Regulation
Cardiac Output, Venous Return, and Their RegulationCardiac Output, Venous Return, and Their Regulation
Cardiac Output, Venous Return, and Their RegulationMedicoseAcademics
 
Physiologic Anatomy of Heart_AntiCopy.pdf
Physiologic Anatomy of Heart_AntiCopy.pdfPhysiologic Anatomy of Heart_AntiCopy.pdf
Physiologic Anatomy of Heart_AntiCopy.pdfMedicoseAcademics
 
ANATOMY AND PHYSIOLOGY OF REPRODUCTIVE SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF REPRODUCTIVE SYSTEM.pptxANATOMY AND PHYSIOLOGY OF REPRODUCTIVE SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF REPRODUCTIVE SYSTEM.pptxSwetaba Besh
 
Jual Obat Aborsi Di Dubai UAE Wa 0838-4800-7379 Obat Penggugur Kandungan Cytotec
Jual Obat Aborsi Di Dubai UAE Wa 0838-4800-7379 Obat Penggugur Kandungan CytotecJual Obat Aborsi Di Dubai UAE Wa 0838-4800-7379 Obat Penggugur Kandungan Cytotec
Jual Obat Aborsi Di Dubai UAE Wa 0838-4800-7379 Obat Penggugur Kandungan Cytotecjualobat34
 
Creeping Stroke - Venous thrombosis presenting with pc-stroke.pptx
Creeping Stroke - Venous thrombosis presenting with pc-stroke.pptxCreeping Stroke - Venous thrombosis presenting with pc-stroke.pptx
Creeping Stroke - Venous thrombosis presenting with pc-stroke.pptxYasser Alzainy
 
Intro to disinformation and public health
Intro to disinformation and public healthIntro to disinformation and public health
Intro to disinformation and public healthTina Purnat
 
ANATOMY AND PHYSIOLOGY OF RESPIRATORY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF RESPIRATORY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF RESPIRATORY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF RESPIRATORY SYSTEM.pptxSwetaba Besh
 
ABO Blood grouping in-compatibility in pregnancy
ABO Blood grouping in-compatibility in pregnancyABO Blood grouping in-compatibility in pregnancy
ABO Blood grouping in-compatibility in pregnancyMs. Sapna Pal
 
Difference Between Skeletal Smooth and Cardiac Muscles
Difference Between Skeletal Smooth and Cardiac MusclesDifference Between Skeletal Smooth and Cardiac Muscles
Difference Between Skeletal Smooth and Cardiac MusclesMedicoseAcademics
 
Dr. A Sumathi - LINEARITY CONCEPT OF SIGNIFICANCE.pdf
Dr. A Sumathi - LINEARITY CONCEPT OF SIGNIFICANCE.pdfDr. A Sumathi - LINEARITY CONCEPT OF SIGNIFICANCE.pdf
Dr. A Sumathi - LINEARITY CONCEPT OF SIGNIFICANCE.pdfSumathi Arumugam
 
The Clean Living Project Episode 23 - Journaling
The Clean Living Project Episode 23 - JournalingThe Clean Living Project Episode 23 - Journaling
The Clean Living Project Episode 23 - JournalingThe Clean Living Project
 
MOTION MANAGEMANT IN LUNG SBRT BY DR KANHU CHARAN PATRO
MOTION MANAGEMANT IN LUNG SBRT BY DR KANHU CHARAN PATROMOTION MANAGEMANT IN LUNG SBRT BY DR KANHU CHARAN PATRO
MOTION MANAGEMANT IN LUNG SBRT BY DR KANHU CHARAN PATROKanhu Charan
 
HISTORY, CONCEPT AND ITS IMPORTANCE IN DRUG DEVELOPMENT.pptx
HISTORY, CONCEPT AND ITS IMPORTANCE IN DRUG DEVELOPMENT.pptxHISTORY, CONCEPT AND ITS IMPORTANCE IN DRUG DEVELOPMENT.pptx
HISTORY, CONCEPT AND ITS IMPORTANCE IN DRUG DEVELOPMENT.pptxDhanashri Prakash Sonavane
 
Drug development life cycle indepth overview.pptx
Drug development life cycle indepth overview.pptxDrug development life cycle indepth overview.pptx
Drug development life cycle indepth overview.pptxMohammadAbuzar19
 
TEST BANK For Guyton and Hall Textbook of Medical Physiology, 14th Edition by...
TEST BANK For Guyton and Hall Textbook of Medical Physiology, 14th Edition by...TEST BANK For Guyton and Hall Textbook of Medical Physiology, 14th Edition by...
TEST BANK For Guyton and Hall Textbook of Medical Physiology, 14th Edition by...rightmanforbloodline
 
Top 10 Most Beautiful Russian Pornstars List 2024
Top 10 Most Beautiful Russian Pornstars List 2024Top 10 Most Beautiful Russian Pornstars List 2024
Top 10 Most Beautiful Russian Pornstars List 2024locantocallgirl01
 
7 steps How to prevent Thalassemia : Dr Sharda Jain & Vandana Gupta
7 steps How to prevent Thalassemia : Dr Sharda Jain & Vandana Gupta7 steps How to prevent Thalassemia : Dr Sharda Jain & Vandana Gupta
7 steps How to prevent Thalassemia : Dr Sharda Jain & Vandana GuptaLifecare Centre
 
Part I - Anticipatory Grief: Experiencing grief before the loss has happened
Part I - Anticipatory Grief: Experiencing grief before the loss has happenedPart I - Anticipatory Grief: Experiencing grief before the loss has happened
Part I - Anticipatory Grief: Experiencing grief before the loss has happenedbkling
 

Recently uploaded (20)

VIP ℂall Girls Arekere Bangalore 6378878445 WhatsApp: Me All Time Serviℂe Ava...
VIP ℂall Girls Arekere Bangalore 6378878445 WhatsApp: Me All Time Serviℂe Ava...VIP ℂall Girls Arekere Bangalore 6378878445 WhatsApp: Me All Time Serviℂe Ava...
VIP ℂall Girls Arekere Bangalore 6378878445 WhatsApp: Me All Time Serviℂe Ava...
 
Cara Menggugurkan Kandungan Dengan Cepat Selesai Dalam 24 Jam Secara Alami Bu...
Cara Menggugurkan Kandungan Dengan Cepat Selesai Dalam 24 Jam Secara Alami Bu...Cara Menggugurkan Kandungan Dengan Cepat Selesai Dalam 24 Jam Secara Alami Bu...
Cara Menggugurkan Kandungan Dengan Cepat Selesai Dalam 24 Jam Secara Alami Bu...
 
Cardiac Output, Venous Return, and Their Regulation
Cardiac Output, Venous Return, and Their RegulationCardiac Output, Venous Return, and Their Regulation
Cardiac Output, Venous Return, and Their Regulation
 
Physiologic Anatomy of Heart_AntiCopy.pdf
Physiologic Anatomy of Heart_AntiCopy.pdfPhysiologic Anatomy of Heart_AntiCopy.pdf
Physiologic Anatomy of Heart_AntiCopy.pdf
 
ANATOMY AND PHYSIOLOGY OF REPRODUCTIVE SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF REPRODUCTIVE SYSTEM.pptxANATOMY AND PHYSIOLOGY OF REPRODUCTIVE SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF REPRODUCTIVE SYSTEM.pptx
 
Jual Obat Aborsi Di Dubai UAE Wa 0838-4800-7379 Obat Penggugur Kandungan Cytotec
Jual Obat Aborsi Di Dubai UAE Wa 0838-4800-7379 Obat Penggugur Kandungan CytotecJual Obat Aborsi Di Dubai UAE Wa 0838-4800-7379 Obat Penggugur Kandungan Cytotec
Jual Obat Aborsi Di Dubai UAE Wa 0838-4800-7379 Obat Penggugur Kandungan Cytotec
 
Creeping Stroke - Venous thrombosis presenting with pc-stroke.pptx
Creeping Stroke - Venous thrombosis presenting with pc-stroke.pptxCreeping Stroke - Venous thrombosis presenting with pc-stroke.pptx
Creeping Stroke - Venous thrombosis presenting with pc-stroke.pptx
 
Intro to disinformation and public health
Intro to disinformation and public healthIntro to disinformation and public health
Intro to disinformation and public health
 
ANATOMY AND PHYSIOLOGY OF RESPIRATORY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF RESPIRATORY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF RESPIRATORY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF RESPIRATORY SYSTEM.pptx
 
ABO Blood grouping in-compatibility in pregnancy
ABO Blood grouping in-compatibility in pregnancyABO Blood grouping in-compatibility in pregnancy
ABO Blood grouping in-compatibility in pregnancy
 
Difference Between Skeletal Smooth and Cardiac Muscles
Difference Between Skeletal Smooth and Cardiac MusclesDifference Between Skeletal Smooth and Cardiac Muscles
Difference Between Skeletal Smooth and Cardiac Muscles
 
Dr. A Sumathi - LINEARITY CONCEPT OF SIGNIFICANCE.pdf
Dr. A Sumathi - LINEARITY CONCEPT OF SIGNIFICANCE.pdfDr. A Sumathi - LINEARITY CONCEPT OF SIGNIFICANCE.pdf
Dr. A Sumathi - LINEARITY CONCEPT OF SIGNIFICANCE.pdf
 
The Clean Living Project Episode 23 - Journaling
The Clean Living Project Episode 23 - JournalingThe Clean Living Project Episode 23 - Journaling
The Clean Living Project Episode 23 - Journaling
 
MOTION MANAGEMANT IN LUNG SBRT BY DR KANHU CHARAN PATRO
MOTION MANAGEMANT IN LUNG SBRT BY DR KANHU CHARAN PATROMOTION MANAGEMANT IN LUNG SBRT BY DR KANHU CHARAN PATRO
MOTION MANAGEMANT IN LUNG SBRT BY DR KANHU CHARAN PATRO
 
HISTORY, CONCEPT AND ITS IMPORTANCE IN DRUG DEVELOPMENT.pptx
HISTORY, CONCEPT AND ITS IMPORTANCE IN DRUG DEVELOPMENT.pptxHISTORY, CONCEPT AND ITS IMPORTANCE IN DRUG DEVELOPMENT.pptx
HISTORY, CONCEPT AND ITS IMPORTANCE IN DRUG DEVELOPMENT.pptx
 
Drug development life cycle indepth overview.pptx
Drug development life cycle indepth overview.pptxDrug development life cycle indepth overview.pptx
Drug development life cycle indepth overview.pptx
 
TEST BANK For Guyton and Hall Textbook of Medical Physiology, 14th Edition by...
TEST BANK For Guyton and Hall Textbook of Medical Physiology, 14th Edition by...TEST BANK For Guyton and Hall Textbook of Medical Physiology, 14th Edition by...
TEST BANK For Guyton and Hall Textbook of Medical Physiology, 14th Edition by...
 
Top 10 Most Beautiful Russian Pornstars List 2024
Top 10 Most Beautiful Russian Pornstars List 2024Top 10 Most Beautiful Russian Pornstars List 2024
Top 10 Most Beautiful Russian Pornstars List 2024
 
7 steps How to prevent Thalassemia : Dr Sharda Jain & Vandana Gupta
7 steps How to prevent Thalassemia : Dr Sharda Jain & Vandana Gupta7 steps How to prevent Thalassemia : Dr Sharda Jain & Vandana Gupta
7 steps How to prevent Thalassemia : Dr Sharda Jain & Vandana Gupta
 
Part I - Anticipatory Grief: Experiencing grief before the loss has happened
Part I - Anticipatory Grief: Experiencing grief before the loss has happenedPart I - Anticipatory Grief: Experiencing grief before the loss has happened
Part I - Anticipatory Grief: Experiencing grief before the loss has happened
 

QPS DMPK

  • 1. TIME IS OF THE ESSENCE IN DRUG DEVELOPMENT. CONTACT THE QPS BUSINESS DEVELOPMENT TEAM TODAY! CALL +1 512 350 2827 EMAIL infobd@qps.com DMPK A flexible approach to QPS DMPK PROVIDES A DEDICATED TEAM OF SENIOR SCIENTISTS TO HELP SELECT, design and conduct the appropriate ADME studies for your specific compounds and therapeutic targets. Working with QPS DMPK is a collaborative and consultative endeavor that also incorporates our operational effectiveness and dedication to customer service.
  • 2. Fargo, ND, USA Dermal and Transdermal Research Laboratory (DTRL) Groningen and Leeuwarden, The Netherlands Bioanalysis (BA) Clinical Research Services (CRS) Translational Medicine (TLM) Suzhou and Shanghai, China Bioanalysis (BA) Clinical Research Services (CRS) Miami, FL, USA Clinical Research Services (CRS) Hyderabad, India Bioanalysis (BA) Clinical Research Services (CRS) Taipei, Taiwan Bioanalysis (BA) Clinical Research Services (CRS) Toxicology (TOX) Newark, DE, USA Bioanalysis (BA) Clinical Research Services (CRS) DMPK Translational Medicine (TLM) Global Headquarters for QPS Holdings LLC Graz, Austria Clinical Research Services (CRS) DMPK Histology Services Neuropharmacology Rare Disease Rodent Biobank Springfield, MO, USA Clinical Research Services (CRS) Macro & Micro Autoradiography One of QPS’ main services in DMPK is the combined mass balance, biliary excretion, PK, and QWBA studies. f Increased efficiency by using a single study protocol f Better study oversight with an integrated study report f Elimination of the possibility of radiolabel degrading over an extended period of time between the two studies f Metabolite profiling and identification can be done using the samples from the same study f Micro-autoradiography provides insight into sub-cellular tissue distribution Biotransformation QPS biotransformation studies determine how a molecule may be altered by the action of enzymes. These study types include: f In vitro metabolic stability in hepatic subcellular fractions to determine intrinsic clearance f In vitro comparison of metabolite formation in animal and human hepatic preparations, using non-labeled and radio-labeled test articles f In vivo metabolite profiling, identification and quantification using samples collected from animal PK, mass balance excretion studies, and human AME studies to satisfy Metabolites in Safety Testing (MIST) Protein Binding QPS protein binding studies determine the extent of protein binding in various plasma species and tissues. f Methods: equilibrium dialysis (RED, Harvard device, 96- well HTD), ultrafiltration, and ultracentrifugation f Discovery screening, in vitro protein binding for IND, and ex vivo studies in clinical phases f Experience in compounds with very high binding, stability issues, or non-specific issues Drug-Drug Interaction QPS drug interaction studies determine the potential of a substance to alter cytochrome P450 activity. Studies conducted to assess inhibition and induction potential to support discovery and development of new drug candidates are: f In vitro inhibition characterization in human liver microsomes or hepatocytes to determine reversible or time dependent IC50 f In vitro mechanistic characterization of reversible inhibitory rate constants Ki f Identification of the reversible mechanism of inhibition as competitive, non-competitive or uncompetitive f In vitro mechanistic characterization of time dependent inhibition Kinact and KI f Identification of the mechanism of time dependent inhibition as metabolite mediated via covalent modification or due to tight binding effect of substrate f In vitro characterization of CYP1A2, CYP2B6, and CYP3A4 induction potential in human hepatocytes based on mRNA and/or CYP activity using isoform selective probe substrates QPS is a Global CRO with locations around the world WWW.QPS.COM